Stéphanie Filleur Selected Research

Neoplasms (Cancer)

1/2018	Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity.
1/2017	PEDF increases the tumoricidal activity of macrophages towards prostate cancer cells in vitro.
4/2013	Positive correlation between PEDF expression levels and macrophage density in the human prostate.
8/2011	PEDF inhibits IL8 production in prostate cancer cells through PEDF receptor/phospholipase A2 and regulation of NFκB and PPARγ.
9/2005	Human breast tumors override the antiangiogenic effect of stromal thrombospondin-1 in vivo.
1/2005	Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.
7/2003	SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphanie Filleur Research Topics

Disease

7	Neoplasms (Cancer) 01/2018 - 07/2003
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2005
2	Neoplasm Metastasis (Metastasis) 09/2005 - 11/2002
1	Prostatitis 04/2013
1	Breast Neoplasms (Breast Cancer) 09/2005
1	Carcinogenesis 09/2005
1	Disease Progression 09/2005
1	Carcinoma (Carcinomatosis) 01/2005
1	Fibrosarcoma 07/2003
1	Bone Resorption 11/2002

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2005 - 07/2003
2	cabazitaxel FDA Link 01/2020 - 01/2018
2	pigment epithelium-derived factorIBA 01/2017 - 08/2011
2	Messenger RNA (mRNA)IBA 01/2017 - 04/2013
2	Hormones (Hormone)IBA 08/2011 - 01/2005
2	Small Interfering RNA (siRNA)IBA 08/2011 - 07/2003
1	taxaneIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Superoxides (Superoxide)IBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 08/2011
1	CytokinesIBA 08/2011
1	pigment epithelium-derived factor receptorIBA 08/2011
1	Phospholipases A2 (Phospholipase A2)IBA 08/2011
1	Extracellular Matrix ProteinsIBA 09/2005
1	Thrombospondin 1IBA 09/2005
1	AndrogensIBA 01/2005
1	Angiogenesis InhibitorsIBA 01/2005
1	Testosterone (Sustanon)FDA Link 01/2005
1	Diphosphonates (Bisphosphonates)IBA 11/2002

Therapy/Procedure

2	Therapeutics 04/2013 - 11/2002